Labshake search
Citations for R&D Systems :
3001 - 3050 of 4069 citations for 3 Methoxy 2 2 4 4 Tetrabde Unlabeled 50 Ug Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Bioengineering 2022Quote: ... follistatin of 100 ng/mL (769-FS-025/CF, R&D system) and a cocktail of myostatin and follistatin (overall 50 ng/mL each ...
-
bioRxiv - Biochemistry 2022Quote: ... and BSA and supplemented with 10 ng/mL Fgf2 (R&D Systems), 20 ng/mL Activin A (R&D Systems ...
-
bioRxiv - Cell Biology 2022Quote: ... and Wnt3a (100 ng/ml, R&D Systems, 1324-WN-002/CF). Treated cells were incubated for 48 hours and Axin2 gene expression was evaluated using the protocol described above ...
-
bioRxiv - Cell Biology 2022Quote: ... 1% ITS+premix and 100ng/ml recombinant CCL2 protein (R&D Systems) or 1% BSA for the control were placed on uncoated or Matrigel coated inserts in the upper compartment ...
-
bioRxiv - Cell Biology 2022Quote: ... and 100 ng ml-1 FGF8a (4745-F8-050, R&D Systems). On day 16-17 ...
-
bioRxiv - Neuroscience 2022Quote: ... and PDGF-AA (10 µg/mL, R&D systems, 233-AA-050). Differentiation-permissive media refers to the same media conditions as OPC growth media with the exclusion of FGF and PDGF.
-
bioRxiv - Neuroscience 2022Quote: ... The media was supplemented with 20 ng/ml FGF2 (R&D Systems) and 20 ng/ml EGF (R&D Systems ...
-
bioRxiv - Microbiology 2022Quote: ... Recombinant SLIT2 (rSLIT2) was added as indicated (R&D Systems, 100ng/mL).
-
bioRxiv - Neuroscience 2022Quote: ... Neural medium was supplemented with 20 ng/ml EGF (R&D Systems) and 20 ng/mL FGF2 (R&D Systems ...
-
bioRxiv - Neuroscience 2022Quote: ... and 20 ng/mL FGF2 (R&D Systems, cat. no. 233-FB). From day 15 of differentiation ...
-
bioRxiv - Developmental Biology 2022Quote: ... and FGF2 (10 ng/ml, R&D Systems, 233-FB-001MG/CF) and NRG1 (10 ng/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... + Dibutyryl-cAMP (SelleckChem; 0.5 mM) + TGFꞵ3 (R&D Systems; 1 ng/ml) + DAPT (ToCris ...
-
bioRxiv - Neuroscience 2024Quote: ... + Dibutyryl-cAMP (SelleckChem; 0.5 mM) + TGFꞵ3 (R&D Systems; 1 ng/ml) + CHIR99021 (SelleckChem ...
-
bioRxiv - Genetics 2023Quote: ... 40 ng ml–1 brain-derived neurotrophic factor (BDNF, R&D Systems), 40 ng ml–1 glial cell line-derived neurotrophic factor (GDNF ...
-
bioRxiv - Immunology 2024Quote: ... and 100 ng/ml human recombinant APRIL/TNFSF-13 (R&D systems). Human healthy donor peripheral blood mononuclear cells (PBMC ...
-
bioRxiv - Developmental Biology 2024Quote: ... and 1 ng/ml human BMP4 (R&D Systems Cat# 314-BP). The media were changed to serum-free differentiation media without additional growth factors after 2 days ...
-
bioRxiv - Cell Biology 2024Quote: ... and recombinant human FGF basic146 aa (10 ng/ml, R&D Systems) for another 2 weeks as previously described37.
-
bioRxiv - Neuroscience 2024Quote: ... Recombinant Human BDNF Protein (1ug/ml, 248-BDB-MTO, R&D Systems), Neurotrophin-3 (1ug/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... Recombinant Human BDNF Protein (1ug/ml, 248-BDB-MTO, R&D Systems), Neurotrophin-3 (1ug/ml ...
-
bioRxiv - Neuroscience 2024Quote: ... and 10ng/ml human basic fibroblast growth factor (bFGF, R&D systems). For the RedSox2 NSC characterization ...
-
bioRxiv - Neuroscience 2024Quote: ... 20 ng ml−1 epidermal growth factor (R&D Systems, 236-EG) and 20 ng ml−1 basic fibroblast growth factor (R&D Systems ...
-
bioRxiv - Developmental Biology 2024Quote: ... all wells were coated with 10 µg/ml fibronectin (R&D Systems). Cells were cultured in DMEM:F12 ...
-
bioRxiv - Immunology 2024Quote: ... 1% P/S containing CCL17 (800ng/ml, R&D Systems, #529-TR), when indicated ...
-
bioRxiv - Immunology 2024Quote: ... with or without 10 µg/ml Fc proteins (R&D Systems Inc.). Mouse T cells were enriched with EasySep™ Mouse T Cell Enrichment Kit (Miltenyi Biotec ...
-
bioRxiv - Immunology 2024Quote: ... primary dFBs were treated with IFNγ (5 ng/ml, R&D Systems) or PBS control for 2 hours ...
-
bioRxiv - Cancer Biology 2024Quote: ... we introduced 200 ng/mL follistatin (4889-FN-025, R&D Systems), an endogenous antagonist for activin (29) ...
-
bioRxiv - Bioengineering 2024Quote: ... supplemented with 10 ng/mL recombinant human IL-7 (R&D Systems). For culture ...
-
bioRxiv - Bioengineering 2024Quote: ... 1 µg/mL R-Spondin1 (Rspo1) (R&D systems; 4645-RS/CF), 100 ng/mL recombinant human FGF10 (Peprotech ...
-
bioRxiv - Cancer Biology 2024Quote: ... mouse VEGFR1/Flt-1 antibody (1 μg/mL, R&D Systems, #AF471), or a combination of anti-VEGFR1 and VEGF-B for 30 hrs ...
-
bioRxiv - Developmental Biology 2023Quote: ... 5 ng/ml BMP7 (R&D Systems, cat# 354-BP-500/CF), and 50 ng/ml BMP12/GDF7 (R&D Systems ...
-
bioRxiv - Developmental Biology 2023Quote: ... 2.5 ng/ml BMP6 (R&D Systems, cat# 507-BP-020/CF), 5 ng/ml BMP7 (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... NIF (1x reconstitution, 200 μg/mL NIF; R&D Systems; Minneapolis, MN) or vehicle (sterile PBS ...
-
bioRxiv - Neuroscience 2023Quote: ... followed by 20 ng/mL EGF (R&D Systems, 236-EG-200) and 20 ng/mL FGF-2 (R&D Systems ...
-
bioRxiv - Neuroscience 2023Quote: ... supplemented with 10 ng/mL BDNF (R&D systems, 248-BD-025), 200 μM Ascorbic Acid (AA ...
-
bioRxiv - Immunology 2023Quote: ... and/or 1.14 μg/mL human recombinant ICAM-1 (R&D system) in DPBS for 1 h at 37°C and blocked with 1.5% (v/v ...
-
bioRxiv - Cell Biology 2023Quote: ... in the presence of 20 ng/ml EGF (R&D Systems Europe). Media were supplemented with 20 ng/ml EGF every 48h ...
-
Polarized Mechanosensitive Signaling Domains Protect Arterial Endothelial Cells Against InflammationbioRxiv - Cell Biology 2023Quote: ... TNF- α (10 ng/mL; R&D Systems #210-TA-020/CF) in the presence of DMSO or GSK1016790A (10nM ...
-
bioRxiv - Immunology 2023Quote: ... 10 µg/mL anti-His tag antibody (clone AD1.1.10, R&D Systems), 50 ng/mL CpG ODN 2006 (Invivogen) ...
-
bioRxiv - Immunology 2023Quote: ... 20 ng/mL human IFN-β (84-99I-F010, R&D Systems), 20 ng/mL human TNF-α (H8916-10UG ...
-
bioRxiv - Neuroscience 2023Quote: ... and fibroblast growth factor 8 (FGF8; 100 ng/mL, R&D Systems). Upon appearance of rosette-like structures (day 14) ...
-
bioRxiv - Bioengineering 2023Quote: ... and 10 ng mL− 1 FGF-10 (human recombinant) (R&D Systems). The cells were then treated with RPMI medium GlutaMax™ Supplement containing 2% (v/v ...
-
bioRxiv - Cell Biology 2023Quote: ... or tumor necrosis factor alpha (TNFα, 20 ng/mL, R&D systems) were used as positive controls.
-
bioRxiv - Cancer Biology 2023Quote: ... murine NRG1 (100 ng mL−1, R&D Systems 9875-NR-050), murine EREG (500 ng mL−1 ...
-
bioRxiv - Developmental Biology 2023Quote: ... 10 ng/ml NT3 (R&D Systems, cat# 267-N3-025/CF) and 100 ng/ml BDNF (R&D Systems ...
-
bioRxiv - Immunology 2023Quote: ... plus 5 ng/mL of recombinant mouse IL-18 (R&D Systems). To retain intracellular mediators for downstream cytofluorimetric analyses ...
-
bioRxiv - Immunology 2023Quote: ... recombinant human CCL2 (100 ng/ml, 279-MC-010; R&D Systems) was added to the cells immediately before loading them into the flow chamber and the CCL2 concentration was maintained during the initial 4 min of the assay.
-
bioRxiv - Immunology 2023Quote: ... IL-1β (20 ng/ml 201-LB-005/CF; R&D Systems) and TNF-α (20 ng/ml 210-TA-005/CF ...
-
bioRxiv - Immunology 2023Quote: ... IL-23 (20 ng/ml, 1290-IL-010/CF; R&D Systems), IL-1β (20 ng/ml 201-LB-005/CF ...
-
bioRxiv - Immunology 2023Quote: ... and 30 ng/ml mouse IFNβ (R&D Systems #8234-MB-010)
-
bioRxiv - Immunology 2023Quote: BMDMs were primed with murine IFNγ (5 ng/ml, R&D systems) for 16 h ...